US2013196010A1PendingUtilityA1
Use of Extracts of Capraria Biflora in the Prevention and/or Treatment of Senile Cataracts
Est. expiryMay 7, 2028(~1.8 yrs left)· nominal 20-yr term from priority
Inventors:Adria Burrows
A61K 9/0048A61P 27/12A61K 36/68A61K 36/80
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides methods for treating and/or preventing the recurrence of a senile cataract, and/or for inhibiting the development of a senile cataract and/or an incipient senile cataract, in a human or animal subject. The invention further provides nutraceutical compositions suited for the same, derived from an extract of the plant Capraria biflora . The compositions comprise the extract in a therapeutically sufficient amount for the treatment and/or prophylaxis of a senile cataract in a human and/or animal subject.
Claims
exact text as granted — not AI-modified1 . A composition useful for the treatment of a senile cataract in a human or animal patient comprising an extract obtained from Capraria biflora , wherein the composition comprises said extract and one or more physiologically acceptable additives.
2 . A composition in accordance with claim 1 wherein said extract is an aqueous extract prepared from the leaves of Capraria biflora.
3 . A composition in accordance with claim 2 wherein said one or more physiologically acceptable additives comprise one or more pharmaceutically acceptable excipients and/or carriers.
4 . A composition for the treatment of a senile cataract in an animal subject comprising an extract of Capraria biflora in a delivery system, wherein the extract comprises an aqueous extract obtained from one or more plant organs selected from the group consisting of the leaves, stems, stalks, twigs, flowers, roots and seeds of Capraria biflora , and wherein the composition is administered to a subject in need of treatment of a senile cataract.
5 . A composition in accordance with claim 4 wherein said animal subject is a mammal.
6 . A composition in accordance with claim 5 wherein said mammalian subject is a human being.
7 . A composition comprising an extract of Capraria biflora in a therapeutically sufficient amount to prevent or retard the development of a senile cataract in an animal subject to which the composition is administered.
8 . A composition in accordance with claim 7 wherein said extract is an aqueous extract prepared from the leaves of Capraria biflora.
9 . A composition in accordance with claim 8 further comprising one or more pharmaceutically acceptable excipients and/or carriers.
10 . A composition for retarding the development of a senile cataract in a subject, comprising an extract of Capraria biflora in a therapeutically sufficient amount to prevent or retard the development of a senile cataract in a subject to whom the composition is administered.
11 . A composition in accordance with claim 10 wherein said extract is an aqueous extract prepared from the leaves of Capraria biflora.
12 . A composition in accordance with claim 11 further comprising one or more pharmaceutically acceptable excipients and/or carriers.
13 . A composition in accordance with claim 12 wherein said subject is a mammalian subject.
14 . A composition in accordance with claim 13 wherein said mammalian subject is a human being.
15 . A nutraceutical mixture containing an extract of Capraria biflora in admixture with suitable excipients and/or carriers, wherein the extract is present in an effective proportion such that, when administered to a subject in a therapeutically effective amount, the mixture is effective to prevent or retard the development of a senile cataract in a subject to whom the mixture is administered.
16 . A mixture in accordance with claim 15 wherein said extract is an aqueous extract prepared from one or more plant organs selected from the group consisting of the leaves, stems, stalks, twigs, flowers, roots and seeds of Capraria biflora.
17 . A mixture in accordance with claim 16 wherein said extract is prepared from the leaves of Capraria biflora.
18 . A mixture in accordance with claim 17 wherein said subject is a human subject.Join the waitlist — get patent alerts
Track US2013196010A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.